Dailypharm Live Search Close

Baxter and Fresenius Medical benefited the most

By Nho, Byung Chul | translator Kim, Jung-Ju

23.07.07 06:00:37

°¡³ª´Ù¶ó 0
Hemodialysis annual medical expenses of 2,634 billion won

Quantum jump in sales of related medical devices when the proportion of peritoneal dialysis is expanded by 10-20%

An increase in the number of patients per year by 10,000


As the Ministry of Health and Welfare's pilot project for home management of peritoneal dialysis patients began in earnest, the sales of Baxter and Fresenius Medical, which supply related products, are also expected to grow exponentially. As of 2022, total domestic hemodialysis patient medical expenses amounted to 2,634 billion won, of which peritoneal dialysis accounted for 4-5%.

According to the hemodialysis adequacy evaluation data in 2018, the number of hemodialysis patients in that year was 90,901, and it is showing an increasing trend of 10,000 each year, which is difficult to find worldwide.

The annual cost of hemodialysis per patient who visits the hospital's artificial kidney ro

Nho, Byung Chul(sasiman@dailypharm.com)
If you want to see the full article, please JOIN US (click)